Browse studies

Find your next paid study

7 recruiting studies matching your filters

Master Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies as Assessed by Biomarker Status and Cognition

This study is a pre-screening process used to assess participants' potential eligibility for Roche interventional Alzheimer's disease studies.

Alzheimers Disease

Estimated

~$10 – $7,500

Hoffmann-La RocheNCT07177352

Observational

Evaluating the Effectiveness of the Health App Recommendation Tool

This study aims to assess the effectiveness of the Health App Recommendation Tool (HART), an evidence-based tool that evaluates app features and matches them t…

Alzheimers Disease Related Dementias

Estimated

~$10 – $6,250

University of PittsburghNCT07216716

Phase 2

A Phase II/III Multicenter Randomized, Double-Blind, Placebo-Controlled, Two-Stage Adaptive Design, Platform Trial of Investigational Treatments for Primary Prevention of Disease Progression in Dominantly Inherited Alzheimer's Disease

The purpose of this research study is to test the study drug, referred to as remternetug, to determine its effectiveness for the study treatment of asymptomati…

Alzheimers DiseaseDementiaAlzheimers Disease, Familial

Estimated

~$10 – $6,250

Washington University School of MedicineNCT06647498

Phase 2

A Phase II/III Multicenter Randomized, Double-Blind, Placebo-Controlled, Two-Stage Adaptive Design, Platform Trial of Investigational Treatments for Primary Prevention of Disease Progression in Dominantly Inherited Alzheimer's Disease

The purpose is to evaluate the biomarker effect, safety, and tolerability of investigational study drugs in participants who are known to have an Alzheimer's d…

Alzheimers DiseaseDementiaAlzheimers Disease, Familial

Estimated

~$10 – $6,250

Washington University School of MedicineNCT05552157

Phase 2

Assessment of Foralumab Safety and Modulation of Microglial Activation Evaluated by PET Imaging in Patients With Early Symptomatic Alzheimer's Disease

This phase 2a study will research the safety and tolerability of Foralumab, a human anti-CD3 antibody. An antibody is a molecule secreted by the immune system.…

DementiaAlzheimers DiseaseMild Cognitive Impairment Due to Alzheimer's Disease

Estimated

~$10 – $6,250

Brigham and Women's HospitalNCT06489548

Observational

Locomotion Adaptation Deficits in Older Adults With Mild Cognitive Impairment and Alzheimers Disease

In people with Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD), reduced capacity for locomotor adaptation is a fundamental but poorly understood m…

Alzheimers DiseaseMild Cognitive Impairment

Estimated

~$10 – $6,250

Emory UniversityNCT06484244

Observational

Scientific Proof of Music Therapy's Impact on Alzheimer's Disease

The purpose of this study is to scientifically validate the impact of music therapy on Alzheimer's disease (AD) by analyzing molecular biomarkers in salivary e…

Alzheimers DiseaseDementiaDementia Alzheimer Type

Estimated

~$10 – $6,250

University of Central FloridaNCT07306065